Determinants of Treatment Willingness and Willingness-to-Pay for Lecanemab in China: A Network Analysis. Tan A, Wang Z, Aumont E, Li A, et al. Alzheimer Dis Assoc Disord 2025;39:223-230.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan A, Wang Z, Aumont E, Li A, et al. Determinants of Treatment Willingness and Willingness-to-Pay for Lecanemab in China: A Network Analysis. Alzheimer Dis Assoc Disord 2025;39:223-230.
PMID: 40955711